Organization Overview
Alternative names
infliximab (remicade) (1 trial)
insulin aspart (Novolog) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
Lactobacillus acidophilus (1 trial)
mercaptopurine (purinethol) (1 trial)
Antigen Peptide-specific DC-CTL Cells (1 trial)
autologous CD276 car-T cells (1 trial)
autologous cd34+ cells (1 trial)
autologous natural killer cells (2 trials)
anti-ny eso-1 tcr-transduced t cells (1 trial)
autologous microbiome (1 trial)
benazepril (lotensin) (1 trial)
carboprost tromethamine (hemabate) (1 trial)
car-cldn18.2 t-cells (1 trial)
Adrenoleukodystrophy (Phase 2)
Arthritis (Phase 4)
Arthritis, Rheumatoid (Phase 4)
beta-Thalassemia (Phase 1)
Breast Neoplasms (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Carcinoma, Small Cell (Phase 1)
Cerebral Infarction (Phase 4)
Cervical Intraepithelial Neoplasia (Phase 1)
Cholangiocarcinoma (Phase 3)
Colorectal Neoplasms (Phase 2)
Communicable Diseases (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Digestive System Neoplasms (Phase 2)
Dwarfism, Pituitary (Phase 4)
Embolism (Phase 4)
Endocrine System Diseases (Phase 4)
Endometriosis (Phase 1)
Gastrointestinal Neoplasms (Phase 2)
Herpangina (Phase 4)
Infections (Phase 4)
Intestinal Neoplasms (Phase 2)
Ischemia (Phase 4)
Kidney Diseases (Phase 2)
Kidney Failure, Chronic (Phase 2)
Leukemia (Phase 4)
Leukemia, Lymphoid (Phase 4)
Leukemia, T-Cell (Phase 3)
Leukodystrophy, Metachromatic (Phase 2)
Lung Neoplasms (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 1)
Nasopharyngeal Carcinoma (Phase 2)
Neoplasms (Phase 2)
Neuroblastoma (Phase 2)
Pulmonary Embolism (Phase 4)
Recurrence (Phase 3)
Respiratory Tract Infections (Phase 4)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Small Cell Lung Carcinoma (Phase 1)
Stomach Neoplasms (Phase 3)
Stroke (Phase 4)
Thalassemia (Phase 1)
Thromboembolism (Phase 4)
Urinary Tract Infections (Phase 4)